Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide combinations in newly diagnosed multiple myeloma (over 65s)
NCT01532856Phase 3Unknown
- Sponsor
- Grupo de Estudos Multicêntricos em Onco-Hematologia
- Start
- Jan 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Grupo de Estudos Multicêntricos em Onco-Hematologia. Status: unknown.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01532856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532856.